Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
- Keyword
-
- MRI (2)
- Adenocarcinoma (1)
- Autoimmunity (1)
- Bovine spongiform encephalopathy (1)
- Bse (1)
-
- CNS (1)
- CT (1)
- Cancer (1)
- Cattle feed (1)
- Cerebral palsy--Treatment; (1)
- Creutzfeldt-jacob disease (1)
- DRB1*1501 (1)
- Esophagus (1)
- Food and drug administration (1)
- Intracranial tuberculoma (1)
- Mad cow disease (1)
- Mammalian protein (1)
- Meat certification program (1)
- Microglia (1)
- Motor neuronopathy (1)
- Multiple sclerosis (1)
- Mycobacterium tuberculosis (1)
- Neuroimaging (1)
- Neurology (1)
- United states department of agriculture (1)
- Publication
- Publication Type
Articles 1 - 6 of 6
Full-Text Articles in Nervous System Diseases
Modified Amino Acid Copolymers Suppress Myelin Basic Protein 85–99-Induced Encephalomyelitis In Humanized Mice Through Different Effects On T Cells, Zsolt Illés, Joel N.H. Stern, Jay Reddy, Hanspeter Waldner, Marcin P. Mycko, Celia F. Brosnan, Stephan Ellmerich, Daniel M. Altmann, Laura Santambrogio, Jack L. Strominger, Vijay K. Kuchroo
Modified Amino Acid Copolymers Suppress Myelin Basic Protein 85–99-Induced Encephalomyelitis In Humanized Mice Through Different Effects On T Cells, Zsolt Illés, Joel N.H. Stern, Jay Reddy, Hanspeter Waldner, Marcin P. Mycko, Celia F. Brosnan, Stephan Ellmerich, Daniel M. Altmann, Laura Santambrogio, Jack L. Strominger, Vijay K. Kuchroo
Jay Reddy Publications
A humanized mouse bearing the HLA-DR2 (DRA/DRB1*1501) pro- tein associated with multiple sclerosis (MS) and the myelin basic protein (MBP) 85–99-specific HLA-DR2-restricted T cell receptor from an MS patient has been used to examine the effectiveness of modified amino acid copolymers poly(F,Y,A,K)n and poly- (V,W,A,K)n in therapy of MBP 85–99-induced experimental auto-immune encephalomyelitis (EAE) in comparison to Copolymer 1 [Copaxone, poly(Y,E,A,K)n]. The copolymers were designed to optimize binding to HLA-DR2. Vaccination, prevention, and treatment of MBP-induced EAE in the humanized mice with copolymers FYAK and VWAK ameliorated EAE more effectively than Copolymer 1, reduced the number of pathological lesions, and …
Neurology In The 21st Century: Contemporary State Of Diagnostics And Therapeutics, Saad Shafqat, Mohammad Wasay
Neurology In The 21st Century: Contemporary State Of Diagnostics And Therapeutics, Saad Shafqat, Mohammad Wasay
Department of Medicine
Although neurological disease has been recognized since antiquity, neurology as a systematic clinical discipline is less than 130 years old. Neurological practice has traditionally been constrained by the complexity of the human nervous system, which has been slow to yield its secrets. Over the last three decades, however, clinical neurology has been transformed in terms of both diagnostics and therapeutics and now marches in lockstep with the cutting edge of medicine. Efficacious treatments are now available for the majority of neurological diseases, including epilepsy, migraine, Guillain-Barre syndrome, Parkinson's disease, multiple sclerosis, and ischemic stroke. This neurological revolution has been enabled …
Motor Neuronopathy Associated With Adenocarcinoma Of Esophagus, Bhojo A Khealani, R. Qureshi, Mohammad Wasay
Motor Neuronopathy Associated With Adenocarcinoma Of Esophagus, Bhojo A Khealani, R. Qureshi, Mohammad Wasay
Department of Medicine
Neurologic paraneoplastic syndromes (NPS) are remote neurologic effects, except metastasis, of systemic cancers. These are a rare group of disorders, commonly associated with small cell lung carcinoma (SCLC).1 Various NPS have been described, including motor neuronopathy. The motor neuronopathy has commonly been described with small cell carcinoma of lung, breast cancer and lymphoproliferative disorders.2,3 We report a case of motor neuronopathy in association with large cell adenocarcinoma of esophagus. To our knowledge this is the first reported case of motor neuronopathy associated with adenocarcinoma of the esophagus.
Prognostic Indicators In Patients With Intracranial Tuberculoma: A Review Of 102 Cases, Mohammad Wasay, M. K. Moolani, J. Zaheer, Bhojo A. Khealani, R. A. Smego, A. R. Sarwari
Prognostic Indicators In Patients With Intracranial Tuberculoma: A Review Of 102 Cases, Mohammad Wasay, M. K. Moolani, J. Zaheer, Bhojo A. Khealani, R. A. Smego, A. R. Sarwari
Department of Medicine
Objective:
To see the characteristics, course and outcome of patients suffering from intracranial tuberculoma.
Methods:
Retrospective review of 102 patients diagnosed as intracranial tuberculoma at a tertiary care center over 10 years.
Results:
A total of 102 cases were seen with an age range of 1 to 75 years (mean, 30 years). Predisposing factors included Diabetes mellitus (8 patients) and pregnancy or puerperium (7 patients). Five pediatric patients had tuberculoma despite documented BCG vaccination. Fever (59%), headache (57%), meningeal irritation (36%) were the commonest presenting features; one-third of patients were drowsy or comatosed at presentation. Cerebrospinal fluid analysis was performed …
Cerebral Palsy: Physical Therapy And Medical Treatment Issues, Jill Pedretti
Cerebral Palsy: Physical Therapy And Medical Treatment Issues, Jill Pedretti
Presidential Scholars Theses (1990 – 2006)
A discussion of the various terms associated with CP as well as the different classifications will precede a review of several randomized controlled trials, case studies, cohort studies and other related articles regarding treatment methods. Specifically, the use of Intrathecal Baclofen Therapy (1TB), Botulinum toxin injections (Botox), Selective Dorsal Rhizotomy, Threshold Electrical Stimulation (TES), and Pediatric Constraint-Induced Movement Therapy will be examined.
Mad Cow Disease: An Approach To Its Containment, Michael B. Abramson
Mad Cow Disease: An Approach To Its Containment, Michael B. Abramson
Journal of Health Care Law and Policy
No abstract provided.